What is the appropriate management of an acute stroke in a patient at 6 months gestation?

Management of Acute Stroke at 6 Months Gestation

Pregnancy should NOT be a contraindication to standard acute stroke treatment—both IV alteplase and mechanical thrombectomy should be administered when indicated, as the benefits of treating a potentially devastating stroke far outweigh the minimal risks to mother and fetus. 1

Immediate Diagnostic Approach

Proceed urgently with neuroimaging without delay:

• Non-contrast head CT is the first-line imaging to rule out hemorrhage—radiation exposure from standard CT protocols is well below the threshold for fetal harm 2
• MRI without gadolinium is preferred if immediately available and provides superior diagnostic accuracy while avoiding radiation entirely 3, 4
• CT angiography should be performed if large vessel occlusion is suspected—the cumulative radiation dose from complete CT-based stroke workup (non-contrast CT + CTA + perfusion) remains below thresholds for serious fetal adverse events 2

Critical point: Do not delay imaging due to pregnancy concerns. The fetal radiation exposure from diagnostic stroke imaging is negligible compared to the catastrophic consequences of untreated maternal stroke.

Reperfusion Therapy Decision-Making

IV Alteplase (tPA)

Administer IV alteplase if the patient presents within 4.5 hours of symptom onset and meets standard eligibility criteria 5, 1, 3:

• Standard dosing: 0.9 mg/kg (maximum 90 mg) over 60 minutes with 10% as initial bolus
• Alteplase is a large molecule that does not cross the placenta 1
• Published data on >200 pregnant patients receiving thrombolytics show: maternal mortality 1%, maternal hemorrhage 8%, fetal loss 6%—comparable to non-pregnant patients 1
• A systematic review of tPA for neurologic indications in pregnancy showed no maternal deaths, no major bleeding, and only 3 fetal losses (none attributed to tPA) 1
• Recent cohort data from Finland demonstrated that IVT-treated maternal stroke patients had significantly more early neurological improvement compared to controls, with only 1 symptomatic ICH (9.1%) and good functional outcomes at 3 months 6

Blood pressure management during tPA in pregnancy: Maintain BP between 140-160/90-110 mmHg during treatment—this is a pregnancy-specific modification from standard protocols 3

Mechanical Thrombectomy

Perform mechanical thrombectomy for large vessel occlusion following the same criteria used in non-pregnant patients 1, 2:

• Pregnancy was excluded from thrombectomy trials, but all available evidence and expert opinion support its use 1
• Radiation exposure during EVT (approximately 1600±500 mGy cumulative) should not be a deciding factor against performing the procedure 1
• Use radiation safety measures: experienced operator as primary, reduced fluoroscopy rate, last image hold, tight collimation, minimize angiography runs 1
• Lead shielding provides minimal actual protection but may offer psychological reassurance 1

Anesthesia consideration: Monitored anesthesia care is preferred over general anesthesia when feasible to avoid fetal exposure to anesthetic agents 7

Supportive Management

Blood Pressure Control

• Target BP <185/110 mmHg before thrombolysis 5
• During pregnancy, maintain slightly higher BP (140-160/90-110 mmHg) during tPA administration 3

Glucose Management

• Maintain glucose 140-180 mg/dL 5
• Treat hypoglycemia (<60 mg/dL) immediately 5

Temperature Control

• Treat fever aggressively—hyperthermia worsens outcomes 3
• Maintain normothermia

Antiplatelet Therapy

• Aspirin 160-325 mg should be initiated 24-48 hours after stroke onset 5
• If tPA was given, delay aspirin until 24 hours post-thrombolysis 5
• Aspirin up to 150 mg daily is safe during pregnancy and lactation 4

Critical Pitfalls to Avoid

1. Do not withhold reperfusion therapy due to pregnancy alone—this is the most common and devastating error
2. Do not delay imaging for "fetal safety" discussions—time is brain, and imaging risks are negligible
3. Do not avoid gadolinium-based contrast if absolutely necessary for diagnosis, though it should be avoided when alternatives exist 2
4. Do not use therapeutic anticoagulation acutely—increases hemorrhagic transformation risk without proven benefit 3

Multidisciplinary Coordination

Immediate involvement required:

• Neurology/stroke team (primary decision-makers)
• Obstetrics (fetal monitoring, delivery planning if needed)
• Anesthesia (if thrombectomy or emergent delivery required)
• Neonatology (standby for potential emergent delivery)

Fetal monitoring should be continuous during procedures but should not delay maternal treatment 7, 8. If fetal distress develops during neurosurgical intervention, emergent cesarean section can be performed in the same operating room without patient transfer 8.

Evidence Quality Note

The 2018 AHA/ASA guidelines 5 provide the framework for stroke management but do not specifically address pregnancy. The 2022 SNIS guidelines 1 directly address pregnancy as a special population and provide the most authoritative guidance, stating that pregnancy should not preclude standard stroke care. Recent case series 6, 9, 10 consistently demonstrate safety and efficacy of reperfusion therapies in pregnancy, with outcomes comparable to non-pregnant patients.